BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹13 Cr | ₹9.65 Cr | ₹6.17 Cr | ₹5.39 Cr | ₹3.02 Cr |
What is the latest Total Non-Current Liabilities ratio of BAFNA PHARMACEUTICALS ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹13 Cr |
Mar2023 | ₹9.65 Cr |
Mar2022 | ₹6.17 Cr |
Mar2021 | ₹5.39 Cr |
Mar2020 | ₹3.02 Cr |
How is Total Non-Current Liabilities of BAFNA PHARMACEUTICALS Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹13 Cr | 32.20 | |
Mar2023 | ₹9.65 Cr | 56.49 | |
Mar2022 | ₹6.17 Cr | 14.52 | |
Mar2021 | ₹5.39 Cr | 78.46 | |
Mar2020 | ₹3.02 Cr | - |
Compare Total Non-Current Liabilities of peers of BAFNA PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAFNA PHARMACEUTICALS | ₹182.3 Cr | 7.3% | 5.3% | -23.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹417,400.0 Cr | -0.3% | 3.1% | 13.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,844.0 Cr | 3.5% | 11% | 63.5% | Stock Analytics | |
CIPLA | ₹121,328.0 Cr | 1.6% | 2.7% | 11.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,521.0 Cr | 4.1% | 4.4% | 24.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,043.0 Cr | 6.8% | 11.3% | 3.1% | Stock Analytics |
BAFNA PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAFNA PHARMACEUTICALS | 7.3% |
5.3% |
-23.2% |
SENSEX | 2.7% |
11.8% |
14% |
You may also like the below Video Courses